Boston Scientific, Coloplast Lead European Erectile Dysfunction Device Market Driven by Three-Piece Implant Popularity
January 18, 2017 (PRLEAP.COM) Health NewsJanuary 18, 2017 - Vancouver, BC – According to a new series of reports on the European market for urological devices by iData Research (www.idataresearch.com), growth in the erectile dysfunction (ED) treatment market is tied to the overwhelming popularity of inflatable devices, which represent over 98% of the total penile implant market. Sales of inflatable devices are driven by the popularity of the three-piece implants. This is due mainly to its superior clinical quality in comparison to the two-piece inflatable alternative. Malleable devices are the least expensive penile implant device with the simplest design and operative procedure, making them the most suitable for patients with limited dexterity.
"The erectile dysfunction treatment device market is driven by the prevalence of diabetes, multiple sclerosis, and increases in the senior population," explains Dr. Kamran Zamanian, CEO of iData. "On the other hand, the market is limited by the use of alternative treatment methods, including vacuum erection devices and, most notably, drug therapy."
Downward pressure on unit sales is due to poor patient awareness of available options, and the fact that the procedure for penile implantation is quite invasive. Reimbursement rates tend not to affect sales volumes of penile implants as much as other products, as the main clientele for these devices tend to be wealthy and prefer private healthcare options over public ones. The average selling price (ASP) is mainly influenced by sales of three-piece inflatable systems, which dominated overall sales.
Three-piece models are the most expensive with an approximate 45% difference in ASP as compared to two-piece devices. With only two leading competitors in the European market, Boston Scientific and Coloplast, the ASP is not greatly affected by pricing pressures. Thus, market growth will be driven mostly by increasing sales volumes.
Boston Scientific's acquisition of American Medical Systems male portfolio led them to gain the majority market share within the European ED device market. The company offers a broad line of penile implant devices including their AMS 700™ MS series of three-piece inflatable devices, their AMS Ambicor® two-piece inflatable device and their AMS Spectra™ Concealable Penile Prosthesis non-inflatable penile implant. Coloplast is the second-leading competitor in the European erectile dysfunction treatment device market with their Titan® line of inflatable penile prosthesis products as well as malleable penile prostheses. One competitive advantage that Coloplast has over Boston Scientific is that they offer a full range of penile implants, including malleable devices.
The company's strategy of focusing on customer satisfaction and directly targeting the needs of their end-users has allowed them to gain market share from Boston Scientific, particularly in sales of their three-piece inflatable devices. Other notable competitors in the European market for erectile dysfunction devices include Promedon and Zephry Surgical Implants among others.
For Further Information
More on the erectile dysfunction device market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite for Urological Devices. The suite covers reports on the following markets: TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices.
The iData report series on urological devices covers the U.S., China, India, Japan and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about urological device market data or procedure data, register online or email us at email@example.com for a European Market Report Suite for Urological Devices brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Peripheral Vascular, Dialysis, Infusion Therapy, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Endoscopy, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.